In response to the health needs of the population, we capture information, analyze and produce the best medicines to generate well-being.
We are committed to developing new dosage forms and creating or improving medical devices, to offer valuable advantages in competitive and niche markets.
We have several lines of pharmaceutical products complying with the highest quality controls, which are classified as follows::
GENERICS Line:
We developed a quality alternative for various prescription drugs such as captopril, carbamazepine, lysine clonixinate, and enalapril, among others.
BIOTECHNOLOGICS Line:
These products are designed to treat ocular, inflammatory, neurodegenerative, and infectious diseases, autoimmune disorders and diabetes using drugs based on antibodies and therapeutic peptides.
Silanes invests in infrastructure and technology to meet the growing demand for products that address actual health needs, achieving optimal quality to maximize the benefit of developed drugs.